Our Transactions
Leadership across the largest and most complex situations
Financial Advisor
~$110 billion sale to
2026
Exclusive Financial Advisor
~$6.9bn sale to
2026
Financial Advisor
$58 billion merger with
2026
Exclusive Advisor
$4.7 billion sale to
2026
Joint-Lead Financial Advisor
merger with
2025
Exclusive Financial Advisor
$10.3 billion sale to
2025
Financial Advisor
~$9.2 billion sale to
2025
Financial Advisor
$12.8 billion merger with
2025
Financial Advisor
$7.4 billion acquisition of
2025
Exclusive Financial Advisor
$12.3 billion sale to
2025
Financial Advisor
separation into two publicly traded companies
2025
Financial Advisor
pending ~$34.5 billion merger with
2025
Lead Financial Advisor
$12 billion sale of a portfolio of natural gas generation facilities and a virtual power plant platform to
2025
Financial Advisor
in connection with its intent to separate
into a standalone public company
2025
Financial Advisor
separation of its Biosciences & Diagnostics Solutions business
2025
Lead Financial Advisor
$29.1 billion sale to
2025
Financial Advisor
$5.1 billion
sale to
2024
|
Anouncement Date1 |
Status |
Transaction |
Value (M) |
|---|---|---|---|
|
March 30, 2026 |
Pending |
Advising J.F. Lehman & Company on its acquisition of Forged Solutions Group |
N/A |
|
March 24, 2026 |
Closed |
Advised Ascent Sports Group on its acquisition of LiveBarn |
N/A |
|
March 19, 2026 |
Closed |
Advised Ercros on Bondalti’s (José de Mello Group) Hostile Takeover Offer |
~€475 |
|
March 18, 2026 |
Pending |
Advising the ad hoc group of Term Loan B lenders on New Fortress Energy’s comprehensive restructuring |
$5,700 |
|
March 13, 2026 |
Pending |
Advising Agero on its acquisition of Urgently |
N/A |
|
March 11, 2026 |
Pending |
Advising Jennmar on a sale of its controlling interest to KPS Capital Partners |
N/A |
|
March 10, 2026 |
Closed |
Acted as lead left bookrunner on Diamondback Energy’s follow-on |
$2,188 |
|
March 10, 2026 |
Pending |
Advising Beazley on its acquisition of kWh Analytics |
N/A |
|
March 5, 2026 |
Closed |
Joint bookrunner on Medline’s follow-on offering |
$3,536 |
|
March 2, 2026 |
Pending |
Advising Beazley on its recommended acquisition by Zurich Insurance Group |
£8,208 |
|
March 2, 2026 |
Pending |
Advising Rallybio on its reverse merger with Candid Therapeutics |
N/A |
|
February 27, 2026 |
Pending |
Advising Warner Bros. Discovery on its sale to Paramount Skydance |
~$110,000 |
|
February 16, 2026 |
Pending |
Advising ZIM on its sale to Hapag-Lloyd |
~$6,900 |
|
February 12, 2026 |
Closed |
Acted as placement agent on Evommune’s PIPE |
$125 |
|
February 11, 2026 |
Pending |
Advising Saltchuk on its acquisition of Great Lakes Dredge & Dock |
~$1,500 |
|
February 11, 2026 |
Closed |
Advised Galecto on its underwritten public offering |
$316 |
|
February 9, 2026 |
Pending |
Advising Transocean on its acquisition of Valaris |
~$5,800 |
|
February 9, 2026 |
Pending |
Advising Evelyn Partners on its sale to NatWest Group |
£2,700 |
|
February 3, 2026 |
Pending |
Advising Energy Assets Group on its sale to Macquarie Asset Management |
N/A |
|
February 2, 2026 |
Pending |
Advising Devon Energy on its merger with Coterra Energy |
$58,000 |
|
February 2, 2026 |
Pending |
Advising Elara Caring on capital structure transactions in connection with a strategic investment from Ares & DaVita |
N/A |
|
January 29, 2026 |
Pending |
Advising International Paper on the spinoff of its EMEA business into a separate publicly listed company |
N/A |
|
January 20, 2026 |
Pending |
Advising GSK on its acquisition of RAPT Therapeutics |
~$2,200 |
|
January 15, 2026 |
Pending |
Advising Clark Capital Management Group on its sale to Raymond James |
N/A |
|
January 14, 2026 |
Pending |
Advising Mission Produce on its acquisition of Calavo Growers |
~$430 |
|
January 6, 2026 |
Pending |
Advising XConn on its sale to Marvell |
$540 |
|
January 6, 2026 |
Closed |
Advised Greenbriar on its acquisition of eShipping |
N/A |
|
January 6, 2026 |
Pending |
Advising Pattern Energy on its private all-stock acquisition of Cordelio Power |
N/A |
|
January 5, 2026 |
Pending |
Advising Cogentrix Energy on its sale to Vistra Corporation |
$4,700 |
|
January 5, 2026 |
Closed |
Acted as active bookrunner on Crinetics Pharmaceuticals’ underwritten public offering |
$350 |
|
January 5, 2026 |
Closed |
Advised TPG on its majority investment in Trustwell |
N/A |
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.